Topical Treatment for Atopic Dermatitis

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT06244212
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
9 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Demonstration of applying triamcinolone cream — OTHER
    Live demonstration of applying 1 fingertip unit of triamcinolone cream
  • Mobile App Use — BEHAVIORAL
    Additional mobile application that provides amount dispensed and adherence data.
  • Standard of Care — OTHER
    Written/verbal instructions only

Study Details

Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.

Key Dates

Start date
Sep 19, 2024
Status verified
Dec 2025
Primary completion
Jul 31, 2026
Completion
Jul 31, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Active Comparator: Demonstration
    Observe a live demonstration instructing how to dispense 1 fingertip unit (FTU) of medication (triamcinolone cream) per 1% body surface area
  • Experimental: Mobile Application
    Additional mobile application that provides instructions to apply the medication (triamcinolone cream)
  • Other: Written/verbal instructions only
    Standard of care written/verbal instructions only

Primary Outcome Measure

Amount of Topical Medication Dispensed - Demonstration Group [ Time Frame: Day 7 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Wake Forest University Health SciencesWinston-SalemNorth Carolina27157
Irma Richardson, MHA
[email protected]
336-716-2903
Steven R Feldman, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Winston-Salem, NC

By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Wake Forest University Health Sciences· Winston-Salem, NC

Related Studies